Top Five Articles on 360Dx Last Week: FDA Regulation of LDTs; Visby FDA Clearance; and More
Last week, readers were most interested in a story about moves by the FDA to regulate LDTs, which could result in legal actions.
Lucira Health won't be the last COVID-19-focused firm to face bankruptcy, layoffs, or stock price declines, as "COVID cash" dries up, experts said.
Chembio Diagnostics Gets CLIA Waiver for HIV-Syphilis Dual Rapid Test
The test can detect both HIV and syphilis from a single sample in 15 minutes using fingerstick blood, venous whole blood, or plasma.
In Brief This Week: Chembio Diagnostics, Thermo Fisher Scientific, Renalytix, Theralink, More
News items for the week of Nov. 28, 2022.
Earnings Roundup: Chembio Diagnostics, Exagen, Opko Health, Biodesix
Chembio, Exagen, and other firms reported quarterly financials this week.
May 6, 2022
Chembio Q1 Revenues More Than Double
Mar 12, 2021
Mar 11, 2021